切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (03) : 251 -253. doi: 10.3877/cma.j.issn.1674-3946.2025.03.006.

论著

76例乙型肝炎肝硬化并发原发性肝癌的高危因素Logistic分析
钱小梅1, 罗洪2, 李智慧2,3, 周代君2, 李东1,2,()   
  1. 1. 646000 四川泸州,西南医科大学附属医院肿瘤科
    2. 610083 成都,中国人民解放军西部战区总医院肿瘤科
    3. 635199 四川大竹,大竹县人民医院
  • 收稿日期:2024-06-11 出版日期:2025-06-26
  • 通信作者: 李东
  • 基金资助:
    国家自然科学基金青年基金(82102920)

Logistic analysis of high-risk factors for primary liver cancer complicating hepatitis b-related liver cirrhosis in 76 cases

Xiaomei Qian1, Hong Luo2, Zhihui Li2,3, Daijun Zhou2, Dong Li1,2,()   

  1. 1. Department of Oncology,Affiliated Hospital of Southwest Medical University,Luzhou Sichuan Province 646000,China
    2. Department of Oncology,General Hospital of Western Theater Command,Chengdu Sichuan Province 610083,China
    3. Dazu County People's Hospital,Dazu Sichuan Province 635199,China
  • Received:2024-06-11 Published:2025-06-26
  • Corresponding author: Dong Li
引用本文:

钱小梅, 罗洪, 李智慧, 周代君, 李东. 76例乙型肝炎肝硬化并发原发性肝癌的高危因素Logistic分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 251-253.

Xiaomei Qian, Hong Luo, Zhihui Li, Daijun Zhou, Dong Li. Logistic analysis of high-risk factors for primary liver cancer complicating hepatitis b-related liver cirrhosis in 76 cases[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(03): 251-253.

目的

分析乙型肝炎(HBV)肝硬化并发原发性肝癌的危险因素,以期为临床诊治提供参考。

方法

回顾性分析2018年7月至2023年7月76例HBV肝硬化并发原发性肝癌患者资料,设为研究组。另选择同期收治的84例HBV肝硬化患者作为对照组。采用SPSS 23.0统计软件对HBV肝硬化并发原发性肝癌的危险因素进行单因素分析与多因素 Logistic回归分析。

结果

单因素分析显示,研究组患者男性、年龄≥65岁、有肝癌家族史、有长期饮酒史、无抗病毒治疗、HBV-DNA定量>2×102 IU/ml均高于对照组,差异有统计学意义(P<0.05)。将差异因素纳入多因素 Logistic回归分析显示,男性、年龄≥65岁、有肝癌家族史、有长期饮酒史、无抗病毒治疗、HBV-DNA定量>2×102 IU/ml是HBV肝硬化并发肝癌的独立危险因素(P<0.05)。

结论

HBV肝硬化并发原发性肝癌的危险因素较多,临床上应对高危患者重点关注。

Objective

To analyze the risk factors for primary liver cancer complicating hepatitis B virus (HBV)-related liver cirrhosis,so as to provide a reference for clinical diagnosis and treatment.

Methods

The data of 76 patients with primary liver cancer complicating HBV-related liver cirrhosis from July 2018 to July 2023 were retrospectively analyzed and set as the study group.Another 84 patients with HBV-related liver cirrhosis admitted during the same period were selected as the control group.The statistical software SPSS 23.0 was used for univariate analysis and multivariate Logistic regression analysis of the risk factors for primary liver cancer.

Result

Univariate analysis showed that the proportions of male gender,age ≥ 65 years old,family history of liver cancer,long-term drinking history,no antiviral treatment,and HBV-DNA quantification > 2×10² IU/ml in the study group were all higher than those in the control group,and the differences were statistically significant (P<0.05).Incorporating the above factors with differences into the multivariate Logistic regression analysis showed that male gender,age ≥ 65 years old,family history of liver cancer,long-term drinking history,no antiviral treatment,and HBV-DNA quantification > 2×10² IU/ml were independent risk factors for liver cancer complicating HBV-related liver cirrhosis (P<0.05).

Conclusion

There are many risk factors for primary liver cancer complicating HBV-related liver cirrhosis,and high-risk patients should be given special attention in clinical practice.

表1 HBV肝硬化并发原发性肝癌的单因素分析(例)
表2 HBV肝硬化并发原发性肝癌多因素Logistic回归分析
[1]
赵刚,刘承利,何晓军,等.高龄复发性小肝癌再治疗方式的择取与安全性比较[J/CD].中华普外科手术学杂志(电子版),2022,16(01): 76-78.
[2]
Xie J,Lin X,Fan X,et al.Global Burden and Trends of Primary Liver Cancer Attributable to Comorbid Type 2 Diabetes Mellitus Among People Living with Hepatitis B: An Observational Trend Study from 1990 to 2019[J].J Epidemiol Glob Health,2024,14(2): 398-410.
[3]
陈孝平,张万广.中国腹腔镜肝癌手术20年回顾与展望[J/CD].中华普外科手术学杂志(电子版),2021,15(04): 355-358.
[4]
O'rourke A.A systematic review of the effects of hepatitis B and C virus on the progression of liver fluke infection to liver cance[rJ].Trop Dis Travel Med Vaccines,2024,10(1): 6.
[5]
Choi WM,Yip TC,Kim WR,et al.Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients[J].Hepatology,2024,12(9): 113-119.
[6]
Ndububa DA.Liver cancer surveillance in people with hepatitis B in Africa[J].Lancet Gastroenterol Hepatol,2024,9(6): 491-492.
[7]
Zovich B,Block SJ,Borondy-Jenkins F,et al.The Role of Culturally Appropriate Mediated Communication Strategies to Reduce Hepatitis B and Liver Cancer Disparities[J].J Health Commun,2024: 1-10.
[8]
Hou JX,Wang YB,Wu J,et al.Clinical significance of serum oxidative stress and serum uric acid levels before surgery for hepatitis B-related liver cancer[J].World J Gastrointest Surg,2023,15(9): 1995-2002.
[9]
Wang SH,Yeh SH,Chen PJ.Androgen Enhances Aflatoxininduced Genotoxicity and Inflammation to Liver Cancer in Male Hepatitis B Patients[J].Cell Mol Gastroenterol Hepatol,2023,15(2): 507-508.
[10]
Singh SP,Jindal A,Sharma MK,et al.Much More Is Needed From Hepatitis B Core-Related Antigen to Predict Risk of Liver Cancer[J].Am J Gastroenterol,2023,118(1): 178.
[11]
Yang C,Geng H,Zhu S,et al.Multiple Diagnostic Indicators in the Development of Chronic Hepatitis B,Liver Cirrhosis,and Liver Cancer[J].Altern Ther Health Med,2023,29(3): 153-159.
[12]
Adugna A.Histomolecular characterisation of hepatitis B virus induced liver cancer[J].Rev Med Virol,2023,33(6): e2485.
[13]
Methods IMC.Retracted: Analysis of Clinical Characteristics of Hepatitis B and Alcohol-Related Liver Cance[rJ].Comput Math Methods Med,2023,2023: 9848121.
[14]
Yun B,Ahn SH,Oh J,et al.Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study[J].Eur J Intern Med,2023,107: 66-72.
[15]
Li YC,Hu WY,Li CH,et al.Differential expression and significance of 5-hydroxymethylcytosine modification in hepatitis B virus carriers and patients with liver cirrhosis and liver cancer[J].World J Gastrointest Surg,2023,15(3): 346-361.
[16]
Tai J,Harrison AP,Chen HM,et al.Acoustic radiation force impulse predicts long-term outcomes in a large-scale cohort: High liver cancer,low comorbidity in hepatitis B virus[J].World J Gastroenterol,2023,29(14): 2188-2201.
[1] 刘庆倩, 乔林霞, 曹亦陶, 孙晓君, 黄锋. 新生儿多重耐药菌感染危险因素及超敏C-反应蛋白与白蛋白比值的诊断价值[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(06): 335-342.
[2] 吉林霞, 范小春, 梁琴. 胃癌常见术后并发症类型及危险因素研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 220-223.
[3] 杨培容, 潘刚, 周春霞. 胰腺癌术后胰瘘的危险因素及治疗进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 228-230.
[4] 林宇腾, 延敏博, 许家榕, 黄子豪, 汤育新. 输尿管软镜手术术后住院时间的影响因素分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 41-46.
[5] 张红鹤, 杜亚君, 严华艳, 胡艳萍, 杨春旭, 王倩. 食管裂孔疝发生的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(01): 92-95.
[6] 李华志, 许臣, 吴永哲. 老年患者经腹腹膜前疝修补术后发生并发症的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(01): 96-98.
[7] 韩金昕, 刘阳, 熊振, 励超, 李嘉良, 王征, 蔡开琳, 王国斌, 陶凯雄, 蔡明. 营养状态对腹腔镜胃癌围手术期静脉血栓栓塞症的影响[J/OL]. 中华腔镜外科杂志(电子版), 2025, 18(01): 19-24.
[8] 吴哲境, 李敬东, 熊永福, 刘刚, 陈雷. 吲哚菁绿在解剖性肝切除术中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 25-29.
[9] 余承澍, 刘红枝, 林科灿, 林起柱, 黄霆峰, 周伟平, 程张军, 楼健颖, 郑树国, 毕新宇, 王剑明, 郭伟, 李富宇, 王坚, 郑亚民, 李敬东, 程石, 曾永毅. 肝内胆管细胞癌术后极早期复发的危险因素[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 53-59.
[10] 张秋月, 张雨, 王杰, 李丽雅, 徐解关玄, 陈香美, 蔡广研. 男性是老年IgA 肾病患者预后不良的危险因素[J/OL]. 中华肾病研究电子杂志, 2025, 14(01): 1-6.
[11] 段红良, 赵红梅, 李涛, 辛建锋. 结直肠癌组织SPOCD1表达与临床病理特征及术后复发转移的关系[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 40-45.
[12] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[13] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
[14] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[15] 文杨, 刘健, 姚海波, 金梅, 杨胜, 马荣川. 超声心动图联合实验室检查预测静脉注射丙种球蛋白无反应性川崎病的价值[J/OL]. 中华诊断学电子杂志, 2025, 13(01): 51-58.
阅读次数
全文


摘要